XRPN EVERNORTH HOLDINGS INC-A
FollowClass A common stock, par value $0.001 per share (common), issuer CIK 2092592
Filings received so far for Q3 2026: 1 13F filer report a position in XRPN shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.
- Alta Partners LLC
1,369,646 shares, 4.9% in a 13G as of 2026-10-19,0001094891-26-000314
Accepted , ingested - Ripple Labs Inc.
2,340,249 shares, 9.9% in a 13G as of 2026-10-09,0000950103-26-015652
Accepted , ingested - Arrington XRP Capital Fund, LP(group Arrington Capital Management, LLC)
4,704,137 shares, 19.9% in a 13G as of 2026-10-09,0001193125-26-425558
Accepted , ingested
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| EverSource Wealth Advisors, LLCin group EverSource Wealth Advisors, L… | 150 | $2.46K | <0.01% | new | 13F-HRTimelineGroup |
Events
Alta Partners LLC reported 1,369,646 XRPN shares, 4.9% of the class, as of 2026-10-19, in a 13G filed 2026-10-28. 0001094891-26-000314
Accepted , ingestedArrington XRP Capital Fund, LP and 2 other reporting persons reported 4,704,137 XRPN shares, 19.9% of the class, as of 2026-10-09, in a 13G filed 2026-10-19. 0001193125-26-425558
Accepted , ingestedRipple Labs Inc. and 2 other reporting persons reported 2,340,249 XRPN shares, 9.9% of the class, as of 2026-10-09, in a 13G filed 2026-10-15. 0000950103-26-015652
Accepted , ingested